George M. Nassar, MD

Associate Professor of Clinical Medicine, Institute for Academic Medicine
Houston Methodist
Weill Cornell Medical College


Education & Training

Clinical Fellowship , Emory University
Internship , Emory University
MD , American University of Beirut
Publications

Open Repair and Venous Inflow Plication of the Arteriovenous Fistula Is Effective in Treating Vascular Steal Syndrome
Patel, MS, Davies, MG, Nassar, GM & Naoum, JJ 2015, Annals of Vascular Surgery, vol 29, no. 5, pp. 927-933. DOI:

Percutaneous Thrombectomy of AVF: Immediate Success and Long-term Patency Rates
Nassar, GM, Rhee, E, Khan, AJ, Nguyen, B, Achkar, K & Beathard, G 2015, Seminars in Dialysis, vol 28, no. 2, pp. E15-E22. DOI:

Outcomes of Cephalic Arch Stenosis With and Without Stent Placement after Percutaneous Balloon Angioplasty in Hemodialysis Patients
Dukkipati, R, Lee, L, Atray, N, Kajani, R, Nassar, G & Kalantar-Zadeh, K 2015, Seminars in Dialysis, vol 28, no. 1, pp. E7-E10. DOI:

Outcomes of Arteriovenous Grafts Following Simultaneous Thrombectomy and Stent Graft Placement Across the Venous Anastomosis
Nassar, GM, Suki, D, Rhee, E, Khan, AJ, Nguyen, B & Achkar, K 2014, Seminars in Dialysis. DOI:

A comparison between the HeRO graft and conventional arteriovenous grafts in hemodialysis patients
Nassar, GM, Glickman, MH, Mclafferty, RB, Kevin Croston, J, Zarge, JI, Katzman, HE, Peden, EK, Lawson, JH, Martinez, JM & Thackeray, L 2014, Seminars in Dialysis, vol 27, no. 3, pp. 310-318. DOI:

Preventing and Treating Inflammation: Role of Dialysis Access Management
Nassar, GM 2013, Seminars in Dialysis, vol 26, no. 1, pp. 28-30. DOI:

Venous angioplasty
Nassar, GM 2012, . in Vascular Access for the General Nephrologist. Nova Science Publishers, Inc. pp. 291-305.

Characteristics of biofilm on tunneled cuffed hemodialysis catheters in the presence and absence of clinical infection
Ramanathan, V, Riosa, S, Al-Sharif, AH, Mansouri, MD, Tranchina, A, Kayyal, T, Abreo, AP, Aslam, S, Nassar, G & Darouiche, RO 2012, American Journal of Kidney Diseases, vol 60, no. 6, pp. 976-982. DOI:

Geringere anzahl von dosisveränderungen bei einmal monatlicher verabreichung von C.E.R.A. bei patienten mit chronischer niereninsuffizienz
Mann, JFE, De Francisco, A, Nassar, G & Canaud, B 2012, Nieren- und Hochdruckkrankheiten, vol 41, no. 9, pp. 367-374. DOI:

Fewer dose changes with once-monthly C.E.R.A. in patients with chronic kidney disease
Mann, JFE, de Francisco, A, Nassar, G & Canaud, B 2011, Clinical Nephrology, vol 76, no. 1, pp. 9-15. DOI:

Long-term performance of the hemodialysis reliable outflow (hero) device: The 56-month follow-up of the first clinical trial patient
Nassar, GM 2010, Seminars in Dialysis, vol 23, no. 2, pp. 229-232. DOI:

Healthcare expenditure and resource utilization in patients with anaemia and chronic kidney disease: A retrospective claims database analysis
Wish, J, Schulman, K, Law, A & Nassar, G 2009, Kidney and Blood Pressure Research, vol 32, no. 2, pp. 110-118. DOI:

Endovascular Management of the "Failing to Mature" Arteriovenous Fistula
Nassar, GM 2008, Techniques in Vascular and Interventional Radiology, vol 11, no. 3, pp. 175-180. DOI:

Postdialysis outcomes associated with consistent anemia treatment in predialysis patients with chronic kidney disease
Wish, JB, Nassar, GM, Schulman, K, del Aguila, M & Provenzano, R 2008, Clinical Nephrology, vol 69, no. 4, pp. 251-259.

C.E.R.A. corrects anemia in patients with chronic kidney disease not on dialysis: Results of a randomized clinical trial
Macdougall, IC, Walker, R, Provenzano, R, de Alvaro, F, Locay, HR, Nader, PC, Locatelli, F, Dougherty, FC, Beyer, U, Altieri, P, Amato, M, Annerstedt, M, Balducci, A, Barre, P, Breen, C, Brown, E, Burgos-Calderon, R, Carpenito, G, Choukroun, G, Craver, L, Culleton, B, de Alvaro, F, Deferrari, G, del Pino y Pino, M, Dragoun, GP, Durand, D, Esnault, V, Evenepoel, P, Faller, B, Fine, A, Fischer, D, Formica, M, Frei, U, Frenken, L, Golper, T, Hagen, C, Hahn, K, Harris, K, Imbasciati, E, Jacquot, C, Jolly, S, Kaysen, G, Kerr, P, Kessler, M, Kopyt, N, Kovesdy, C, Kraut, J, Kwan, J, Lafayette, R, Laville, M, Levin, A, Locatelli, F, Locay, HR, Lok, C, Macdougall, IC, MacPhee, I, Franco, JEM, Castelao, AM, McMahon, A, Ruiz, EM, Muirhead, N, Murphy, S, Nader, PC, Nassar, GM, Noble, S, Papadakis, G, Papadakis, I, Penfield, J, Pichette, V, Provenzano, R, Pylypchuk, G, Risler, T, Puyol, DR, Rosansky, S, Sakellariou, G, Schmidt, R, Siamopoulos, K, Solomon, R, Spinowitz, B, Stegmayr, B, Suranyi, M, Tam, P, Tobe, S, Vargemezis, V, Vela, C, Villa, G, Walker, R, Warr, K, Wijeyesinghe, C, Woitas, R & Zoccali, C 2008, Clinical Journal of the American Society of Nephrology, vol 3, no. 2, pp. 337-347. DOI:

Intravenous methoxy polyethylene glycol-epoetin beta for haemoglobin control in patients with chronic kidney disease who are on dialysis: a randomised non-inferiority trial (MAXIMA)
Levin, NW, Fishbane, S, Cañedo, FV, Zeig, S, Nassar, GM, Moran, JE, Villa, G, Beyer, U & Oguey, D 2007, Lancet, vol 370, no. 9596, pp. 1415-1421. DOI:

What should nephrologists do to maximize the use of arteriovenous fistulas?
Nassar, GM 2006, Seminars in dialysis, vol 19, no. 3, pp. 207-209. DOI:

Endovascular treatment of the "failing to mature" arteriovenous fistula.
Nassar, GM, Nguyen, B, Rhee, E & Achkar, K 2006, Clinical journal of the American Society of Nephrology : CJASN, vol 1, no. 2, pp. 275-280. DOI:

First- and second-generation immunometric PTH assays during treatment of hyperparathyroidism with cinacalcet HCl
Martin, KJ, Jüppner, H, Sherrard, DJ, Goodman, WG, Kaplan, MR, Nassar, G, Campbell, P, Curzi, M, Charytan, C, McCary, LC, Guo, MD, Turner, SA & Bushinsky, DA 2005, Kidney International, vol 68, no. 3, pp. 1236-1243. DOI:

Salvage of a severely dysfunctional arteriovenous fistula with a strictured and occluded outflow tract
Achkar, K & Nassar, GM 2005, Seminars in Dialysis, vol 18, no. 4, pp. 336-342. DOI: